Synonyms: Kimyrsa® | LY-333328 | LY333328 | Orbactiv®
oritavancin is an approved drug (FDA (2014), EMA (2015))
Compound class:
Synthetic organic
Comment: Oritavancin is a semi-synthetic glycopeptide antibacterial drug [1]. It is structurally related to vancomycin, and likewise is active against several Gram-positive organisms including methicillin resistant Staphylococcus aureus (MRSA). Like dalbavancin, it offers the option of single-dose administration.
|
|
Bioactivity Comments |
The MIC for antimicrobial activity against Streptococcus Group F clinical isolates is 0.5 ng/ml [1]. |